Title : Double attack strategy for leukemia using a pre-targeting bispecific antibody (CD20 Ab-mPEG scFv) and actively attracting PEGylated liposomal doxorubicin to enhance anti-tumor activity.

Pub. Date : 2021 Jan 9

PMID : 33422061






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 This combination achieves the therapeutic function and simultaneously "grabs" Lipo-Dox (PEGylated liposomal doxorubicin, PLD) to enhance the cellular internalization and anticancer activity of PLD. Doxorubicin glycosylphosphatidylinositol specific phospholipase D1 Homo sapiens